Home / Import refusals / 8T9-0026977-6/11/1

FDA Import Refusal 8T9-0026977-6/11/1 — Novartis Manufacturing NV

Novartis Manufacturing NV — FEI 3002037047

The FDA refused shipment 8T9-0026977-6/11/1 from Novartis Manufacturing NV (Belgium) on December 3, 2021. The refused product falls under Drugs and Biologics — REVLIMID. Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
December 3, 2021
Country
Belgium
Product Category
Drugs and Biologics
Product Code
61CCY03 REVLIMID
Charges
75

Recent inspections

  • 1305248 (VAI Wed Mar 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1152317 (VAI Thu Apr 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1126883 (VAI Fri Nov 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 997972 (VAI Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 874952 (NAI Wed Mar 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • AEK-5763396-6/11/1 (Mon Oct 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-6480757-9/21/1 (Tue Oct 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-2074595-0/11/1 (Wed Jan 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-0794946-5/11/1 (Tue Aug 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-1379770-7/31/1 (Wed Jul 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources